01 Challenge
A leading Egyptian pharmaceutical group with a diversified presence across pharmaceutical manufacturing, healthcare, and clinical research engaged Beacon FinTrain to strengthen the financial capabilities of its R&D teams.
The organization needed to make finance more relevant to the decisions its teams encounter in their work, particularly around R&D project costs, budgeting, resource allocation, financial performance, and investment decisions.
The challenge was to move beyond general finance fundamentals and create a learning experience connected to the realities of a pharmaceutical R&D environment.
02 Approach
Beacon FinTrain designed and delivered a 12-hour Financial Management Strategies workshop for 18 managers with pharmaceutical backgrounds, delivered over two days in a classroom setting.
What the Program Focused On
The program focused on three key areas:
-
01
Financial Performance
-
02
R&D Costing
-
03
Strategic Planning & Budgeting
How Participants Applied the Learning
Rather than relying only on theory, participants worked through practical scenarios, including:
Financial Health Assessment
A practical exercise in reading an organization’s financial performance signals.
Clinical Trial Costing Simulation
Working through the real cost structure of an R&D project.
CapEx Committee Role Play
Practicing how an investment decision is evaluated.
Why the Approach Mattered
These activities helped participants apply financial concepts to situations relevant to pharmaceutical R&D, from calculating project costs to evaluating investment decisions.
03 Results
Participants found the learning experience relevant, practical, and applicable to their roles.
100%
Attendance
4.55/5
Overall Participant Evaluation
Participant Evaluation Breakdown
4.64/5
Relating to the instructor’s examples & real-life experience
4.55/5
Applying the learning to their jobs
4.45/5
Gaining knowledge and skills relevant to their roles
The result was a focused learning experience that connected financial management with the realities of pharmaceutical R&D, giving participants a more practical understanding of the financial side of their work.
